Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02839707
Brief Title: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

First Submitted : July 20, 2016
First Submitted that Met QC Criteria : July 20, 2016
First Posted : July 21, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : February 20, 2020
Last Update Posted : February 21, 2020 (Estimate)